Adapting Drug Supply Strategies To Modern Study Models

Throughout the evolution and experienced complexities of decentralized trials (DCTs), we've witnessed an expansion of accessibility to clinical research by directly involving geographically diverse patient populations. Emphasizing the critical role of effective supply chain management, particularly in pharmaceutical logistics, Parexel adapts practices to accommodate direct-to-patient (DtP) models amidst regulatory developments. Challenges such as maintaining drug stability during transport, ensuring security and managing risk highlight the necessity for robust risk management strategies.

To combat these issues, trials will require logistical flexibility, balancing the benefits of DtP shipments—improved patient compliance and retention—with considerations of cost and regulatory compliance. Anticipating advancements such as remote-access drug refrigerators and smart packaging, Parexel advocates for patient-centric trial models that integrate virtual and site-based activities to effectively address diverse patient needs.